Stock Track | Aspen Aerogels Plunges 27.91% on Disappointing Q1 Guidance and Halting Facility Construction

Stock Track
02-13

Aspen Aerogels Inc. (ASPN) stock plummeted 27.91% in intraday trading on Wednesday, following the company's release of its fourth-quarter 2024 financial results and disappointing guidance for the first quarter of 2025.

While Aspen Aerogels reported better-than-expected Q4 revenue and earnings, beating analysts' estimates, the market reacted negatively to its weak Q1 2025 guidance. The company provided a Q1 revenue guidance range of $75 million to $95 million, significantly lower than the consensus estimate of $104.22 million. Additionally, its Q1 EPS guidance range of ($0.18) to $0.00 fell short of the consensus estimate of $0.08.

Adding to the stock's decline, Aspen Aerogels also announced that it is halting the construction of its Statesboro manufacturing facility, citing the need to focus resources on its existing operations.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10